Investor profile
GrayBella Capital
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
GrayBella Capital is a pan-European growth-stage venture capital firm investing in HealthTech and Deep Tech companies. In HealthTech, the firm targets advancements in diagnostics, biomarker discovery, MedTech, remote patient monitoring, and platform technologies for drug development. In Deep Tech, investments span material science, robotics, SaaS platforms, IoT, cloud computing, AI, machine learning, and nanotechnologies. The firm partners with purpose-driven founders developing globally disruptive technologies, invests €3–15M per company over the life of the investment, leads or co-leads rounds, and focuses on pan-European companies with a preference for B2B models and clear liquidity pathways.
Notable quotes
“Omnio has secured a significant market position, that will allow it to be a critical player in the Banking as a Service market.”
Team
Ruta Laukien
Managing Partner
Juan Naranjo
Principal
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Sensius | Series A | $17m | 2025-06-11 |
| Omnio | Convertible Note | $33m | 2021-03-24 |
| ATAI Life Sciences | Series B+ | — | — |
| CN Bio | Series B+ | — | — |
| BC Platforms | Growth | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| European Innovation Council (EIC) | 1 |
| UCEA | 1 |
| Europa | 1 |
| UNIIQ | 1 |
| Opentech | 1 |
Fit check
Is GrayBella Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit